Metastatic Bladder Large Cell Neuroendocrine Carcinoma

specific

A bladder large cell neuroendocrine carcinoma that has spread to another anatomical site.

37

Centers

37

Active Trials

—

Cancer Funding

Top Centers for Metastatic Bladder Large Cell Neuroendocrine Carcinoma(37)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
Active Research Program
51.4
2
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
Active Research Program
51.4
3
UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC
NCI Comprehensive
Active Research Program
51.4
4
UPMC Hillman Cancer CenterPittsburgh, PA
NCI Comprehensive
Active Research Program
51.4
5
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
Active Research Program
51.4
6
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
Active Research Program
51.4
7
Herbert Irving Comprehensive Cancer CenterNew York, NY
NCI Comprehensive
Active Research Program
51.4
8
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
51.4
9
UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
Active Research Program
51.4
10
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
51.4
11
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
51.4
12
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
Active Research Program
51.4
13
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
Active Research Program
51.4
14
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
51.4
15
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
Active Research Program
51.4
16
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
Active Research Program
51.4
17
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
51.4
18
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
Active Research Program
51.4
19
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
51.4
20
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
51.4
21
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
51.4
22
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
Active Research Program
51.4
23
Georgetown Lombardi Comprehensive Cancer CenterWashington, DC
NCI Comprehensive
Active Research Program
51.4
24
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
51.4
25
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
51.4
26
University of Illinois Cancer CenterChicago, IL
Active Research Program
51.4
27
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
Active Research Program
51.4
28
Cancer Center at IllinoisUrbana, IL
Active Research Program
51.4
29
Penn State Cancer InstituteHershey, PA
Active Research Program
51.4
30
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
51.4
31
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
Active Research Program
51.4
32
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
Active Research Program
51.4
33
University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR
Active Research Program
51.4
34
Northwell Health Cancer InstituteNew York, NY
Active Research Program
51.4
35
Upstate Cancer CenterSyracuse, NY
Active Research Program
51.4
36
University of Texas Medical Branch Cancer CenterGalveston, TX
Active Research Program
51.4
37
Louisiana Cancer Research CenterNew Orleans, LA
Active Research Program
51.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →